Skip to content

Smoking Treatment in HIV Clinical Care Settings

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00297453
Enrollment
207
Registered
2006-02-28
Start date
2006-01-31
Completion date
2011-01-31
Last updated
2012-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence

Brief summary

The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.

Interventions

BEHAVIORALInternet-based smoking treatment

All participants have access to an Internet-based self-help intervention that includes social support through message boards. All participants have access to 10 weeks of nicotine replacement treatment.

Six individual counseling sessions are provided over a 12 week treatment period. Participants also have access to a 10-week nicotine replacement treatment.

BEHAVIORALself-help

Participants receive a self-help manual and have access to a 10 nicotine replacement treatment.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV positive * 18 years or older * smoking most days during the past month * must be able to read English

Exclusion criteria

* any contraindications for over-the-counter nicotine replacement treatment * active psychotic symptoms * severe cognitive deficits/dementia

Design outcomes

Primary

MeasureTime frame
7 day point prevalence biochemically verified abstinence rates3, 6, 9, and 12 months following treatment initiation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026